OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival
Carla Garza-Lombó, Annika Schroder, Elsa M. Reyes‐Reyes, et al.
Current Opinion in Toxicology (2018) Vol. 8, pp. 102-110
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Healthy Effects of Plant Polyphenols: Molecular Mechanisms
Manuela Leri, Maria Scuto, Maria Laura Ontario, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1250-1250
Open Access | Times Cited: 363

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 116

Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease
Anchal Trisal, Abhishek Kumar Singh
Neuroscience (2025) Vol. 567, pp. 235-248
Closed Access | Times Cited: 2

Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221
Rania M. Salama, Ghada A. Abdel‐Latif, Samah S. Abbas, et al.
Neuropharmacology (2019) Vol. 164, pp. 107900-107900
Closed Access | Times Cited: 115

The neuroprotective effects of intermittent fasting on brain aging and neurodegenerative diseases via regulating mitochondrial function
Yihang Zhao, Mengzhen Jia, Weixuan Chen, et al.
Free Radical Biology and Medicine (2022) Vol. 182, pp. 206-218
Closed Access | Times Cited: 50

The Athlete Gut Microbiome and its Relevance to Health and Performance: A Review
Marcus O’Brien, Órla O’Sullivan, Marcus J. Claesson, et al.
Sports Medicine (2022) Vol. 52, Iss. S1, pp. 119-128
Open Access | Times Cited: 39

From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer
Abdulrahman Alhajahjeh, Ra'ad Al‐Faouri, Hisham F. Bahmad, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1538-1538
Open Access | Times Cited: 11

Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
Lee Jy, Richie R. Bhandare, Sai H. S. Boddu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116275-116275
Open Access | Times Cited: 9

Research Progress on Alzheimer's Disease and Resveratrol
Yan Yan, Huihuang Yang, Yuxun Xie, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 989-1006
Closed Access | Times Cited: 68

Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders
Chang Shan, Arijit Ghosh, Xingzhi Guo, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 59

Training vs. Tolerance: The Yin/Yang of the Innate Immune System
Trim Lajqi, Natascha Köstlin‐Gille, Reinhard Bauer, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 766-766
Open Access | Times Cited: 21

Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
Chiara Lanzillotta, Monika Rataj Baniowska, Francesca Prestia, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106523-106523
Open Access | Times Cited: 7

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?
Russell Esterline, Jan Oscarsson, Jeffrey M. Burns
International review of neurobiology (2020), pp. 113-140
Closed Access | Times Cited: 41

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
Gabriela Dumitriṭa Stanciu, Răzvan Nicolae Rusu, Veronica Bild, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 576-576
Open Access | Times Cited: 36

Growth or death? Control of cell destiny by mTOR and autophagy pathways
Mahmoud Khalil, Mohamad Moustafa Ali, Jasmine Holail, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 185, pp. 39-55
Closed Access | Times Cited: 16

The role of resveratrol in neurogenesis: a systematic review
Ali Azargoonjahromi, Fatemeh Abutalebian, Fatemeh Hoseinpour
Nutrition Reviews (2024)
Closed Access | Times Cited: 5

Beyond Insulin: The Intriguing Role of GLP-1 in Parkinson's Disease
Aanchal Verma, Ahsas Goyal
European Journal of Pharmacology (2024) Vol. 982, pp. 176936-176936
Closed Access | Times Cited: 5

Insights into Potential Targets for Therapeutic Intervention in Epilepsy
Cecilia Zavala‐Tecuapetla, Manola Cuéllar‐Herrera, Hiram Luna‐Munguía
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8573-8573
Open Access | Times Cited: 38

mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain
Radhika Chadha, Khaled Alganem, Robert E. McCullumsmith, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6868-6879
Closed Access | Times Cited: 28

Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes
Yixiao Ma, Hua Liu, Yong Wang, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22

Neuronal ablation of GHSR mitigates diet-induced depression and memory impairment via AMPK-autophagy signaling-mediated inflammation
Hongying Wang, Zheng Shen, Chia‐Shan Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus
Shumei Cao, Jiao Jiang, Haoyuan Yin, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112149-112149
Closed Access | Times Cited: 4

Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?
M. Barone
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2391-2396
Open Access | Times Cited: 4

A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer
Jui-Hsiang Li, Pei-Yi Hsin, Yung-Chia Hsiao, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3017-3017
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top